VXRT
Vaxart, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.50
+0.51%Margins
Gross margin
100.0%
EBITDA margin
19.4%
EBIT margin
16.3%
Net margin
15.9%
FCF margin
13.7%
46.8%
Return on equity
23.4%
Return on assets
43.9%
Return on invested capital
1.41x
Asset turnover
$34.0M
Cash from operations
$0.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026